Search

everythinglearnresearchcommunity

for

Search:↓

Acupressure improves quality of life in PCOS patients.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Anabolic steroid users may face higher risk of severe COVID-19.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Estrogen therapy can reduce skin aging but has cancer risks.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone improves mood and thinking skills; finasteride has no effect.

Dutasteride is more efficient than finasteride, but individual results vary.